Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2022-06-28 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議配息基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from a company regarding the board resolution on the dividend distribution date, including details such as the dividend amount, ex-dividend date, record date, and payment date. It does not contain financial statements or detailed financial analysis but rather provides specific dividend payment information. The document length is only 675 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2022-06-28 Chinese
110年企業ESG資訊揭露
Environmental & Social Information Classification · 95% confidence The document contains detailed data and narrative on environmental, social, and governance (ESG) aspects such as greenhouse gas emissions, energy management, water resource management, waste management, employee welfare, board composition, and investor communication frequency. It focuses on sustainability metrics and corporate social responsibility rather than financial performance or regulatory filings. The content aligns with Environmental & Social Information (ESG) reporting. The document length is 2377 characters, which is consistent with a focused ESG report rather than a full annual or interim financial report. Therefore, the appropriate classification is Environmental & Social Information (SR).
2022-06-23 Chinese
111年05月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-06-12 Chinese
111年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is focused on insider share ownership and changes, with no financial statements, earnings data, or management discussion. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, not a report announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-06-12 Chinese
111年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of any report publication or certification. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a general regulatory announcement. The document length is very short (602 characters), and it does not indicate it is an announcement of a report or a certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-06-10 Chinese
111年5月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (772 characters), and it is essentially a revenue summary update. This fits best with an Interim / Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year, specifically monthly and year-to-date revenue figures with comparative data. It is not an announcement of a report, nor a full annual report or earnings release. Therefore, the classification is IR with high confidence.
2022-06-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.